When oxygen runs short: The microenvironment drives host-pathogen interactions

Microbes and Infection

Volumn 14, Issue 4, 2012, Pages 311-316

  Dietz, Inga ^a   Jerchel, Stefan ^a   Szaszák, Márta ^a   Shima, Kensuke ^a   Rupp, Jan ^a,b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Host pathogen interactions; Hypoxia; Hypoxia inducible factor 1

Indexed keywords

CD31 ANTIGEN; CHEMOKINE RECEPTOR CCR2; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1 INHIBITOR; PATTERN RECOGNITION RECEPTOR; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VASCULOTROPIN;

ADAPTATION; ADAPTIVE IMMUNITY; AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANGIOGENESIS; ANTIMICROBIAL THERAPY; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL SURVIVAL; BIOFILM; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; COXIELLA BURNETII; CYTOKINE RELEASE; DRUG METABOLISM; ENDOTHELIUM CELL; ESCHERICHIA COLI; GENE EXPRESSION; HELICOBACTER PYLORI; HEPATITIS B; HEPATITIS B VIRUS; HERPES SIMPLEX VIRUS 1; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN PARVOVIRUS B19; HYPOXIA; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL MEMORY; INFECTION CONTROL; INNATE IMMUNITY; LEISHMANIA; LIVER CELL CARCINOMA; MICROENVIRONMENT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; REGULATORY T LYMPHOCYTE; RNA INTERFERENCE; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; UPREGULATION; VIRUS INFECTION; VIRUS REPLICATION;

ADAPTIVE IMMUNITY; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CELL HYPOXIA; CELLULAR MICROENVIRONMENT; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; OXYGEN CONSUMPTION;

EID: 84858001273     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.11.003     Document Type: Short Survey

References (65)

1. Sommer F., Caspers H.P., Esders K., Klotz T., Engelmann U. Measurement of vaginal and minor labial oxygen tension for the evaluation of female sexual function. J. Urol. 2001, 165:1181-1184.
2. Vaupel P., Wendling P., Thome H., Fischer T.J. Respiratory gas exchange and glucose uptake by the human spleen in situ (author's transl). Klin. Wochenschr. 1977, 55:239-242.
3. Piovan E., Tosello V., Indraccolo S., Masiero M., Persano L., Esposito G., Zamarchi R., Ponzoni M., Chieco-Bianchi L., la-Favera R., Amadori A. Differential regulation of hypoxia-induced CXCR4 triggering during B-cell development and lymphomagenesis. Cancer Res. 2007, 67:8605-8614.
4. Aebersold D.M., Burri P., Beer K.T., Laissue J., Djonov V., Greiner R.H., Semenza G.L. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 2001, 61:2911-2916.
5. Mancino A., Schioppa T., Larghi P., Pasqualini F., Nebuloni M., Chen I.H., Sozzani S., Austyn J.M., Mantovani A., Sica A. Divergent effects of hypoxia on dendritic cell functions. Blood 2008, 112:3723-3734.
6. Bosco M.C., Puppo M., Blengio F., Fraone T., Cappello P., Giovarelli M., Varesio L. Monocytes and dendritic cells in a hypoxic environment: spotlights on chemotaxis and migration. Immunobiology 2008, 213:733-749.
7. Nizet V., Johnson R.S. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 2009, 9:609-617.
8. Bruick R.K., McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001, 294:1337-1340.
9. Peyssonnaux C., Datta V., Cramer T., Doedens A., Theodorakis E.A., Gallo R.L., Hurtado-Ziola N., Nizet V., Johnson R.S. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 2005, 115:1806-1815.
10. Schodel J., Oikonomopoulos S., Ragoussis J., Pugh C.W., Ratcliffe P.J., Mole D.R. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 2011, 117:e207-e217.
11. Kim H., Peng G., Hicks J.M., Weiss H.L., Van Meir E.G., Brenner M.K., Yotnda P. Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment. Mol. Ther. 2008, 16:599-606.
12. Gale D.P., Maxwell P.H. The role of HIF in immunity. Int. J. Biochem. Cell Biol. 2010, 42:486-494.
13. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., Birrer P., Bellon G., Berger J., Weiss T., Botzenhart K., Yankaskas J.R., Randell S., Boucher R.C., Doring G. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 2002, 109:317-325.
14. Cramton S.E., Ulrich M., Gotz F., Doring G. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect. Immun. 2001, 69:4079-4085.
15. Schwarzmann S., Boring J.R. Antiphagocytic effect of slime from a mucoid strain of Pseudomonas aeruginosa. Infect. Immun. 1971, 3:762-767.
16. Omsland A., Cockrell D.C., Howe D., Fischer E.R., Virtaneva K., Sturdevant D.E., Porcella S.F., Heinzen R.A. Host cell-free growth of the Q fever bacterium Coxiella burnetii. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4430-4434.
17. Omsland A., Cockrell D.C., Fischer E.R., Heinzen R.A. Sustained axenic metabolic activity by the obligate intracellular bacterium Coxiella burnetii. J. Bacteriol. 2008, 190:3203-3212.
18. Raleigh J.A., Miller G.G., Franko A.J., Koch C.J., Fuciarelli A.F., Kelly D.A. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumors. Br. J. Cancer 1987, 56:395-400.
19. Varghese A.J., Gulyas S., Mohindra J.K. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by chinese-hamster ovary cells and Kht tumor-cells invitro and invivo. Cancer Res. 1976, 36:3761-3765.
20. Fercher A., O'Riordan T.C., Zhdanova A.V., Dmitriev R.I., Papkovsky D.B. Imaging of cellular oxygen and analysis of mammalian cells. Live Cell Imaging 2009, 257-273. Humana Press, New York. D.B. Papkovsky (Ed.).
21. Stephens R.S., Kalman S., Lammel C., Fan J., Marathe R., Aravind L., Mitchell W., Olinger L., Tatusov R.L., Zhao Q., Koonin E.V., Davis R.W. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998, 282:754-759.
22. Kalman S., Mitchell W., Marathe R., Lammel C., Fan J., Hyman R.W., Olinger L., Grimwood J., Davis R.W., Stephens R.S. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat. Genet. 1999, 21:385-389.
23. Kana B.D., Weinstein E.A., Avarbock D., Dawes S.S., Rubin H., Mizrahi V. Characterization of the cydAB-encoded cytochrome bd oxidase from Mycobacterium smegmatis. J. Bacteriol. 2001, 183:7076-7086.
24. Juul N., Jensen H., Hvid M., Christiansen G., Birkelund S. Characterization of in vitro chlamydial cultures in low-oxygen atmospheres. J. Bacteriol. 2007, 189:6723-6726.
25. Rupp J., Gieffers J., Klinger M., van Z.G., Wrase R., Maass M., Solbach W., Deiwick J., Hellwig-Burgel T. Chlamydia pneumoniae directly interferes with HIF-1alpha stabilization in human host cells. Cell Microbiol. 2007, 9:2181-2191.
26. Roth A., Konig P., van Zandbergen G., Klinger M., Hellwig-Burgel T., Daubener W., Bohlmann M.K., Rupp J. Hypoxia abrogates antichlamydial properties of IFN-gamma in human fallopian tube cells in vitro and ex vivo. Proc. Natl. Acad. Sci. U. S. A 2010, 107:19502-19507.
27. Wayne L.G., Lin K.Y. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect. Immun. 1982, 37:1042-1049.
28. Schnappinger D., Ehrt S., Voskuil M.I., Liu Y., Mangan J.A., Monahan I.M., Dolganov G., Efron B., Butcher P.D., Nathan C., Schoolnik G.K. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 2003, 198:693-704.
29. Wolfle D., Schmidt H., Jungermann K. Short-term modulation of glycogen metabolism, glycolysis and gluconeogenesis by physiological oxygen concentrations in hepatocyte cultures. Eur. J. Biochem. 1983, 135:405-412.
30. Davis D.A., Rinderknecht A.S., Zoeteweij J.P., Aoki Y., Read-Connole E.L., Tosato G., Blauvelt A., Yarchoan R. Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood 2001, 97:3244-3250.
31. Cai Q., Lan K., Verma S.C., Si H., Lin D., Robertson E.S. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: latency control under low oxygen conditions. J. Virol. 2006, 80:7965-7975.
32. Aghi M.K., Liu T.C., Rabkin S., Martuza R.L. Hypoxia enhances the replication of oncolytic herpes simplex virus. Mol. Ther. 2009, 17:51-56.
33. Pillet S., Le G.N., Hofer T., NguyenKhac F., Koken M., Aubin J.T., Fichelson S., Gassmann M., Morinet F. Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells. Virology 2004, 327:1-7.
34. Harrison J.S., Rameshwar P., Chang V., Bandari P. Oxygen saturation in the bone marrow of healthy volunteers. Blood 2002, 99:394.
35. Servais C., Caillet-Fauquet P., Draps M.L., Velu T., de L.Y., Brandenburger A. Hypoxic-response elements in the oncolytic parvovirus minute virus of mice do not allow for increased vector production at low oxygen concentration 1. J. Gen. Virol. 2006, 87:1197-1201.
36. Lee S.W., Lee Y.M., Bae S.K., Murakami S., Yun Y., Kim K.W. Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis. Biochem. Biophys. Res. Commun. 2000, 268:456-461.
37. Moon E.J., Jeong C.H., Jeong J.W., Kim K.R., Yu D.Y., Murakami S., Kim C.W., Kim K.W. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. FASEB J. 2004, 18:382-384.
38. McGovern N.N., Cowburn A.S., Porter L., Walmsley S.R., Summers C., Thompson A.A., Anwar S., Willcocks L.C., Whyte M.K., Condliffe A.M., Chilvers E.R. Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils. J. Immunol. 2011, 186:453-463.
39. Hannah S., Mecklenburgh K., Rahman I., Bellingan G.J., Greening A., Haslett C., Chilvers E.R. Hypoxia prolongs neutrophil survival in vitro. FEBS Lett. 1995, 372:233-237.
40. Walmsley S.R., Print C., Farahi N., Peyssonnaux C., Johnson R.S., Cramer T., Sobolewski A., Condliffe A.M., Cowburn A.S., Johnson N., Chilvers E.R. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J. Exp. Med. 2005, 201:105-115.
41. Winning S., Splettstoesser F., Fandrey J., Frede S. Acute hypoxia induces HIF-independent monocyte adhesion to endothelial cells through increased intercellular adhesion molecule-1 expression: the role of hypoxic inhibition of prolyl hydroxylase activity for the induction of NF-kappa B. J. Immunol. 2010, 185:1786-1793.
42. Kalra V.K., Shen Y., Sultana C., Rattan V. Hypoxia induces PECAM-1 phosphorylation and transendothelial migration of monocytes. Am. J. Physiol. 1996, 271:H2025-H2034.
43. Bosco M.C., Puppo M., Santangelo C., Anfosso L., Pfeffer U., Fardin P., Battaglia F., Varesio L. Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J. Immunol. 2006, 177:1941-1955.
44. Negus R.P., Turner L., Burke F., Balkwill F.R. Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors. J. Leukoc. Biol. 1998, 63:758-765.
45. Turner L., Scotton C., Negus R., Balkwill F. Hypoxia inhibits macrophage migration. Eur. J. Immunol. 1999, 29:2280-2287.
46. Anand R.J., Gribar S.C., Li J., Kohler J.W., Branca M.F., Dubowski T., Sodhi C.P., Hackam D.J. Hypoxia causes an increase in phagocytosis by macrophages in a HIF-1alpha-dependent manner. J. Leukoc. Biol. 2007, 82:1257-1265.
47. Colhone M.C., rrais-Silva W.W., Picoli C., Giorgio S. Effect of hypoxia on macrophage infection by Leishmania amazonensis. J. Parasitol. 2004, 90:510-515.
48. Yun J.K., McCormick T.S., Villabona C., Judware R.R., Espinosa M.B., Lapetina E.G. Inflammatory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:13903-13908.
49. Leeper-Woodford S.K., Detmer K. Acute hypoxia increases alveolar macrophage tumor necrosis factor activity and alters NF-kappaB expression. Am. J. Physiol. 1999, 276:L909-L916.
50. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A.S., Nizet V., Johnson R.S., Haddad G.G., Karin M. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008, 453:807-811.
51. Shi L.Z., Wang R., Huang G., Vogel P., Neale G., Green D.R., Chi H. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and treg cells. J. Exp. Med. 2011, 208:1367-1376.
52. Kojima H., Kobayashi A., Sakurai D., Kanno Y., Hase H., Takahashi R., Totsuka Y., Semenza G.L., Sitkovsky M.V., Kobata T. Differentiation stage-specific requirement in hypoxia-inducible factor-1alpha-regulated glycolytic pathway during murine B cell development in bone marrow. J. Immunol. 2010, 184:154-163.
53. Caldwell C.C., Kojima H., Lukashev D., Armstrong J., Farber M., Apasov S.G., Sitkovsky M.V. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J. Immunol. 2001, 167:6140-6149.
54. Zuckerberg A.L., Goldberg L.I., Lederman H.M. Effects of hypoxia on interleukin-2 mRNA expression by T lymphocytes. Crit. Care Med. 1994, 22:197-203.
55. Roman J., Rangasamy T., Guo J., Sugunan S., Meednu N., Packirisamy G., Shimoda L.A., Golding A., Semenza G., Georas S.N. T-cell activation under hypoxic conditions enhances IFN-gamma secretion. Am. J. Respir. Cell Mol. Biol. 2010, 42:123-128.
56. zur Wiesch P.A., Kouyos R., Engelstadter J., Regoes R.R., Bonhoeffer S. Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infect. Dis. 2011, 11:236-247.
57. Bosquillon C. Drug transporters in the lung-do they play a role in the biopharmaceutics of inhaled drugs?. J. Pharm. Sci. 2010, 99:2240-2255.
58. Tulkens P.M. Intracellular distribution and activity of antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 1991, 10:100-106.
59. Shima K., Szaszak M., Solbach W., Gieffers J., Rupp J. Impact of a low-oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatis. Antimicrob. Agents Chemother. 2011, 55:2319-2324.
60. Babic Z., Svoboda-Beusan I., Kucisec-Tepes N., Dekaris D., Troskot R. Increased activity of Pgp multidrug transporter in patients with Helicobacter pylori infection. World J. Gastroenterol. 2005, 11:2720-2725.
61. Comerford K.M., Wallace T.J., Karhausen J., Louis N.A., Montalto M.C., Colgan S.P. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 2002, 62:3387-3394.
62. Lenaerts A.J., Hoff D., Aly S., Ehlers S., Andries K., Cantarero L., Orme I.M., Basaraba R.J. Location of persisting mycobacteria in a guinea pig model of tuberculosis revealed by r207910. Antimicrob. Agents Chemother. 2007, 51:3338-3345.
63. Deb C., Lee C.M., Dubey V.S., Daniel J., Abomoelak B., Sirakova T.D., Pawar S., Rogers L., Kolattukudy P.E. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS One 2009, 4:e6077.
64. Schaible U.E., Kaufmann S.H. A nutritive view on the host-pathogen interplay. Trends Microbiol. 2005, 13:373-380.
65. Nairz M., Schroll A., Sonnweber T., Weiss G. The struggle for iron - a metal at the host-pathogen interface. Cell Microbiol. 2010, 12:1691-1702.